<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Cell Therapeutics Inc. | Company News & Executive Profiles - CTIC | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/cell+therapeutics+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Cell Therapeutics Inc.]]></description>
	<s:counts start="0" returned="10" found="18" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Cell Therapeutics Looks Good, Antigenics Looks Better]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F160377-cell-therapeutics-looks-good-antigenics-looks-better%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[VFC submits:  In response to a number of requests that I've received via email or comments asking for 'VFC's Take' on numerous stocks that readers have found, I'll do my best to address as many as I can, as long as everyone takes a few things into account while...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 08 Sep 2009 03:30:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/vfc%2527s+stock+house.html"><![CDATA[VFC's Stock House]]></category>
		<category domain="http://resources.bnet.com/topic/antigenics+inc..html"><![CDATA[Antigenics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cell+therapeutics+inc..html"><![CDATA[Cell Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AGEN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
		<category domain="tickers">AGEN,CTIC</category>
	</item>
	<item>
		<title><![CDATA[FDA Calendar Update: Cell Therapeutics]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F152172-fda-calendar-update-cell-therapeutics%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 285 entries as of 7/29/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 29 Jul 2009 08:23:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/cell+therapeutics+inc..html"><![CDATA[Cell Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
		<category domain="tickers">CTIC</category>
	</item>
	<item>
		<title><![CDATA[Spectrum Pharmaceuticals: Oversold and Undervalued]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F148709-spectrum-pharmaceuticals-oversold-and-undervalued%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[In Monday trading, Spectrum Pharmaceuticals (Nasdaq: SPPI) closed at $4.98 with a market cap of $193 million. Shares broke through and closed below their 50-day MA, $5.02. This suggests that shares of the drug maker are likely oversold.  Data Source: e-Signal. by Justin M. Hall]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 14 Jul 2009 08:52:17 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/justin+m.+hall.html"><![CDATA[Justin M. Hall]]></category>
		<category domain="http://resources.bnet.com/topic/cell+therapeutics+inc..html"><![CDATA[Cell Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/spectrum+pharmaceuticals+inc..html"><![CDATA[Spectrum Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SPPI</category>
		<category domain="tickers">CTIC,SPPI</category>
	</item>
	<item>
		<title><![CDATA[Spectrum Pharmaceuticals: Temporary Setback]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F147141-spectrum-pharmaceuticals-temporary-setback%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Yesterday, Spectrum Pharmaceuticals (Nasdaq: SPPI) announced receipt of a Complete Response Letter (CRL) for Zevalin from the FDA. SPPI submitted a supplemental Biologics License Application sBLA earlier this year for the use of Zevalin as a first-line consolidation therapy for the treatment of non-Hodgkin&#8217;s lymphoma (NHL). Zevalin is currently approved...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 06 Jul 2009 06:12:04 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/justin+m.+hall.html"><![CDATA[Justin M. Hall]]></category>
		<category domain="http://resources.bnet.com/topic/cell+therapeutics+inc..html"><![CDATA[Cell Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/spectrum+pharmaceuticals+inc..html"><![CDATA[Spectrum Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SPPI</category>
		<category domain="tickers">CTIC,SPPI</category>
	</item>
	<item>
		<title><![CDATA[FDA Calendar Updates: Cell Therapeutics, OncoGenex Pharma]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F145119-fda-calendar-updates-cell-therapeutics-oncogenex-pharma%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 24 Jun 2009 07:48:05 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/cell+therapeutics+inc..html"><![CDATA[Cell Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
		<category domain="tickers">CTIC</category>
	</item>
	<item>
		<title><![CDATA[Access Pharma: Preparing to Advance Pipeline]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F142635-access-pharma-preparing-to-advance-pipeline%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Since I last wrote about Access Pharma (ACCP.OB) two weeks ago as a cancer biotech call option trade, the Company has issued two updates on its clinical development pipeline and two updates for MuGard &#8211; which is an oral rinse product for the management of a common...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 11 Jun 2009 03:56:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/cell+therapeutics+inc..html"><![CDATA[Cell Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
		<category domain="tickers">CTIC</category>
	</item>
	<item>
		<title><![CDATA[Cell Therapeutics Likely to Move Higher on Significant Cancer Study News]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F141088-cell-therapeutics-likely-to-move-higher-on-significant-cancer-study-news%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[After flaming all sorts of rumors with its 'Modified Dutch Auction' Tender Offer press release after the market closed on Tuesday, shares of the biopharmaceutical company Cell Therapeutics, Inc. CTIC are likely to move higher after a key development was revealed very early this morning.   The company, which...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 03 Jun 2009 05:08:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/m.+e.+garza.html"><![CDATA[M. E. Garza]]></category>
		<category domain="http://resources.bnet.com/topic/cell+therapeutics+inc..html"><![CDATA[Cell Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
		<category domain="tickers">CTIC</category>
	</item>
	<item>
		<title><![CDATA[Cell Therapeutics' Turnaround Remains on Track]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F136399-cell-therapeutics-turnaround-remains-on-track%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: The dramatic turnaround from lows of a nickel per share ealier this year at cancer biotech Cell Therapeutics (NASDAQ:CTIC) remains on track as the Company announced its 1Q09 results Thursday, which included a 76% reduction of net loss and expected completion of the pixantrone NDA filing this...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 08 May 2009 04:36:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/cell+therapeutics+inc..html"><![CDATA[Cell Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/spectrum+pharmaceuticals+inc..html"><![CDATA[Spectrum Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SPPI</category>
		<category domain="tickers">CTIC,SPPI</category>
	</item>
	<item>
		<title><![CDATA[Cell Therapeutics Is down but Not Out]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F118129-cell-therapeutics-is-down-but-not-out%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Cell Therapeutics CTIC is a micro-cap cancer biotech which is down substantially in the past year in terms of stock price and market value, but not out after recently establishing a joint venture with Spectrum Pharma SPPI to market Zevalin, the potential for two FDA approvals this...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 03 Feb 2009 04:50:28 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/cell+therapeutics+inc..html"><![CDATA[Cell Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/spectrum+pharmaceuticals+inc..html"><![CDATA[Spectrum Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SPPI</category>
		<category domain="tickers">CTIC,SPPI</category>
	</item>
	<item>
		<title><![CDATA[Cell Therapeutics, Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-223998.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question comes from Vernon Bernardino &#8211; Rodman & Renshaw. Vernon Bernardino &#8211; Rodman & Renshaw I&#8217;m wondering if you could go over what factors drove sales of Zevalin in second quarter that were later than sales in the first quarter? James Bianco What...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 18 Aug 2008 08:25:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cell+therapeutics+inc..html"><![CDATA[Cell Therapeutics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CTIC</category>
		<category domain="tickers">CTIC</category>
	</item>
</channel>
</rss>
